Matthias C. Grieshaber

Canaloplasty with Stegmann Canal Expander for primary open-angle glaucoma: two-year clinical results.

Canaloplasty with the Stegmann Canal Expander was a safe and effective procedure to reduce IOP in White patients with moderate to advanced POAG.

Access to Schlemm's canal for canaloplasty: an intra-individual comparison of two dissection techniques.

In this intra-individual comparative study of ab externo canaloplasty with the canal expander, IOP reduction was substantial in both groups and slightly greater in the group with deep scleral flap excision.

Comparison of Outcomes of Deep Sclerectomy, Canaloplasty, and Viscocanaloplasty: A Multicenter Study.

All 3 NPGS provide sustained IOP reduction, but DS and CP provide better success rates and IOP control.

A New Expander for Schlemm Canal Surgery in Primary Open-angle Glaucoma-Interim Clinical Results.

Implantation of the Stegmann Canal Expander in canaloplasty lowered IOP significantly in POAG without complications related to the device in this 1-year observation period.

Novel device for expanding Schlemm's canal: a morphological study: Implantation of the Stegmann Canal Expander following viscodilation of Schlemm's canal resulted in permanent expansion of the canal lumen and distension of the trabecular meshwork without complications.

This may increase the permeability of the trabecular meshwork, reduce its resistance to aqueous humour and maintain circumferential flow within SC.

Long-term results of up to 12 years of over 700 cases of viscocanalostomy for open-angle glaucoma.

Viscocanalostomy produced a sustained long-term reduction of IOP with a low-risk profile in European and African patients with OAG over 12 years.